Combining Ipilimumab with local treatments improved survival for patients with melanoma
Ipilimumab is an immunotherapy that has revolutionized the treatment of malignant melanoma, a very aggressive type of skin cancer, according to Theurich. About 20 percent of patients who receive ipilimumab achieve durable ...
Jul 27, 2016
0
7